UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 12, 2022
Accession Number:
0001140361-22-025736
Submission Type:
POS AM
CIK:
0001724344
Company Name:
Entasis Therapeutics Holdings Inc.
File Number:
333-249315